Characterisation of bladder cancer drug responses in organoids and ex vivo models

by M. Kiener, S. Karkampouna, F. La Manna, M. De Menna, G.N. Thalmann, R. Seiler-Blarer, M. Kruithof-De Julio
Published 2020-07-01

Molecular signatures of bone metastatic breast and prostate cancer

by F. La Manna, M. De Menna, E. Rodrigues Sousa, M. De Filippo, P. Kloen, L. Beimers, G.N. Thalmann, M. Kruithof-De Julio
Published 2020-07-01

Radical cystectomy: The significance of hospital volume and surgeon volume. A systematic review and recommendations by the EAU MIBC Guideline Panel

by H.M. Bruins, E. Veskimae, V. Hernandez, Y. Neuzillet, M. Rouanne, R. Cathomas, E.M. Compérat, N.C. Cowan, G. Gakis, E.L. Espinós, A. Lorch, M.J. Ribal, G.N. Thalmann, Y. Yuan, A.G. Van Der Heijden, J.A. Witjes
Published 2020-07-01

Personalised organoid drug treatment and therapy resistance characterization based on novel BRCA2 prostate cancer xenograft of SPOP-like phenotype and microsatellite instability

by S. Karkampouna, F. La Manna, M.R. De Filippo, M. De Menna, E. Zoni, J. Grosjean, I. Klima, A. Garofoli, V. Genitsch, D. Keller, T.H. Booij, C.U. Stirnimann, A. Sboner, C.K.Y. Ng, S. Piscuoglio, M. Spahn, A.R. Mark, G.N. Thalmann, M. Kruithof-De Julio
Published 2020-07-01